Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (2 active)

Company-led only

1 result

Therapy	Approach	Progress	Population	Additional Info
Neramexane by MerzMerz Pharmaceuticals GmbH Compare	Small Molecule	Stage: Phase 3Status: Completed	Adults · 18–75 yearsPersistent subjective tinnitus

Merz Pharmaceuticals GmbH · Small Molecule · Phase 3

CompletedTherapeutic

Population

Adults · 18–75 years

Persistent subjective tinnitus

Evidence

publication

Confidence

86%

Indications

Tinnitus

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.